Monday Mar 3
Aetna and Medtronic Collaborate to Help Members Take Better Control of Type 2 Diabetes
Program aims to improve patients' quality of life and enhance support for doctors to help create more value in the health care system -- )--Beginning this month, Aetna and Medtronic, Inc. will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump ... (more)
Monday Mar 3
Merging Healthcare With Modern Communications Technology
Modern communications technology is starting to have a real impact on the way patients are managing their diseases and the delivery of healthcare.
Zacks Reiterates Neutral Rating for Medtronic
's stock had its "neutral" rating reaffirmed by Zacks in a research note issued on Thursday, Analyst RN reports.
The Business Journal
Medtronic's Santa Rosa group third-quarter sales rise
Medtronic, Inc. on Tuesday reported global fiscal third-quarter sales for its Santa Rosa-based Cardiac and Vascular group of $2.119 billion, up 1 percent from a year before.
Medtronic (MDT) Posts Quarterly Earnings, Hits Estimates
Medtronic announced its earnings results on Tuesday. The company reported $0.91 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.91, American Banking News reports.
Medtronic (MDT) Set to Announce Quarterly Earnings on Tuesday
Medtronic will be announcing its earnings results on Tuesday, February 18th. Medtronic has set its FY14 guidance at $3.80-3.85 EPS.Parties interested in participating in the company's conference call can do so using this link .
Medtronic sells anti-snoring tech, and MN gains
A deal by Medtronic Inc. to jettison an anti-snoring product to a Dallas clinic will return the manufacturing of the technology to Minnesota, where it was developed by the former Restore Medical.
Insulin Pump Market & Forecast - Worldwide Analysis
Insulin pumps are gaining a lot of attraction in United States and European countries.